Please login to the form below

Not currently logged in
Email:
Password:

European Respiratory Society

This page shows the latest European Respiratory Society news and features for those working in and with pharma, biotech and healthcare.

AZ hopes dosing will differentiate its severe asthma therapy

AZ hopes dosing will differentiate its severe asthma therapy

The UK pharma group reported the results of two studies at the European Respiratory Society (ERS) in London, which showed the interleukin-5 (IL-5) inhibitor was able to reduce attacks

Latest news

  • Roche says Esbriet boosts survival in pulmonary fibrosis Roche says Esbriet boosts survival in pulmonary fibrosis

    Roche says Esbriet boosts survival in pulmonary fibrosis. Positive results due to be presented at European Respiratory Society . ... deal. The new data - due to be presented to doctors for the first time at the European Respiratory Society (ERS)

  • Boehringer in breach over beer drinking, lederhosen presentation Boehringer in breach over beer drinking, lederhosen presentation

    standards. The breach comes after a pulmonologist working in Germany complained about a scientific symposium organised by Boehringer at the European Respiratory Society (ERS) Congress, held in Munich last year. ... Boehringer currently markets the

  • GSK sees COPD future in triple therapy GSK sees COPD future in triple therapy

    The performance of GSK's respiratory portfolio dragged down group revenues as a whole last year, and GSK is now banking on a series of new products launches - including LAMA/LABA ... One set back for the triple therapies came last year, however, when a

  • Questions raised about affordability of asthma antibodies Questions raised about affordability of asthma antibodies

    GlaxoSmithKline (GSK) and Teva presented positive phase III trials of their respective anti-IL-5 candidates mepolizumab and reslizumab at this week's European Respiratory Society (ERS) meeting in Munich, showing

  • Boehringer's Spiriva cleared for asthma in EU Boehringer's Spiriva cleared for asthma in EU

    Approval by the European Medicines Agency (EMA) was based on the results of a phase III trial programme - called UniTinA-asthma - that collectively showed that Spiriva reduced the risk of severe ... Boehringer has also presented new data at the European

More from news
Approximately 1 fully matching, plus 22 partially matching documents found.

Latest Intelligence

  • Integrating digital: developing a social conference Integrating digital: developing a social conference

    More recently the company has been forging ahead in its use of tweetchats - during the European Respiratory Society Congress in 2013 it used this forum to spark conversations on chronic obstructive ... More recently it engaged digital efforts for a

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics